Edgewise Therapeutics, Inc.EWTXNASDAQ

Revenue (LTM)

Net Income (LTM)

$-168M

-25.4% YoY

Free Cash Flow

$-144M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	-2
Operating Income	-43	-72↓65.8%	-114↓59.6%	-159↓38.9%	-191↓20.5%
Net Income	-43	-68↓58.0%	-100↓48.1%	-134↓33.6%	-168↓25.4%
EBITDA	-43	-71↓65.6%	-113↓58.4%	-157↓39.0%	-166↓5.7%
EPS Diluted	-0.86	-1.26↓46.5%	-1.57↓24.6%	-1.45↑7.6%	-1.63↓12.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	16	22↑41.3%	86↑291.5%	42↓51.6%	61↑46.8%
Total Current Assets	284	357↑25.8%	327↓8.4%	475↑45.4%	543↑14.3%
Total Assets	285	367↑28.7%	340↓7.4%	487↑43.2%	553↑13.5%
Total Current Liabilities	11	17↑57.6%	17↑1.1%	24↑42.3%	27↑14.7%
Total Liabilities	11	20↑87.9%	21↑4.0%	28↑30.2%	30↑9.9%
Total Equity	274	347↑26.4%	319↓8.0%	459↑44.0%	522↑13.7%
Total Debt	0	4	5↑22.8%	5↓12.5%	4↓15.8%
Net Debt	-16	-18↓13.0%	-81↓358.8%	-37↑54.2%	-57↓54.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-34	-53↓57.1%	-92↓74.7%	-109↓18.6%	-144↓31.9%
Capital Expenditure	-1	-6↓730.2%	-6↓3.6%	-1↑77.2%	-0↑80.5%
Free Cash Flow	-34	-58↓70.2%	-98↓67.9%	-110↓12.9%	-144↓30.3%
Stock-Based Comp	4	11↑148.0%	18↑60.7%	25↑40.7%	0
Net Change in Cash	-89	6↑107.2%	64↑897.4%	-44↓169.3%	19↑143.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance